Greg Madison appointed CEO of Shield Therapeutics
LONDON, UK: Shield Therapeutics plc (LON: STX) announced that Greg Madison has been appointed as Chief Executive Officer (CEO) with effect from Tuesday, 1 June 2021. Greg has an excellent commercialisation track record and, in particular, he has deep knowledge and previous experience in the US iron deficiency marketplace. Greg is a seasoned executive who…